Status:
COMPLETED
Comparison of Pulmonary Telerehabilitation and Physical Activity Recommendations in Patients With Post Covid Fibrosis
Lead Sponsor:
Istanbul University - Cerrahpasa
Collaborating Sponsors:
Health Institutes of Turkey
Conditions:
COVID-19
Pulmonary Fibrosis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Rehabilitation plays a very important role in the management of patients with COVID-19, focusing on respiratory and motor functions, and therefore the importance of establishing treatment strategies t...
Eligibility Criteria
Inclusion
- \>18 years old
- Patients who have been infected with the COVID-19 virus at least three months ago and have been diagnosed with a positive PCR
- Patients with post-COVID-19 pulmonary fibrosis followed by a pulmonologist
- Patients who have sufficient technological infrastructure to participate in the telerehabilitation program and can adapt to online systems
- Patients who are clinically stable
Exclusion
- Patients with orthopedic/neurological problems that prevent walking and exercise
- Patients with uncontrolled cardiovascular disease
- Patients with uncontrolled medical conditions
Key Trial Info
Start Date :
September 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 7 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05299333
Start Date
September 4 2022
End Date
March 7 2025
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University-Cerrahpasa
Istanbul, Turkey (Türkiye)